Multisource Drugs
Multisource drugs are medications available from more than one manufacturer, typically because generic equivalents exist alongside or after a brand product. The availability of multiple sources fosters price competition and influences formulary and reimbursement decisions.
What are multisource drugs?
Multisource drugs are medications available from more than one manufacturer, a situation that typically arises once generic equivalents enter the market alongside or after the original branded product. Because multiple companies can produce the same active ingredient, the drug is no longer tied to a single source.
This contrasts with single-source drugs, which remain available from only one manufacturer, often while still under patent protection. The presence of several therapeutically equivalent options is the defining feature of a multisource product.
Why do multisource drugs matter for pricing and formularies?
Multiple sources of the same medication create price competition, which generally lowers acquisition costs and shapes how payers set reimbursement. Pricing benchmarks for multisource products often reflect this competition, influencing how much purchasers expect to pay.
Formulary and purchasing decisions frequently favor multisource drugs when clinically appropriate because of their lower cost and reliable availability. Understanding which products are multisource is therefore important to managing pharmacy spend and contracting.
- multisource drugs meaning
- what are multisource drugs
- multisource drug definition
- multi-source drugs
- multisource vs single source drugs
- generic multisource medications